ESGO-ESHRE-ESGE Guidelines of fertility sparing treatment in endometrial cancer patients The European Society of Gynaecological Oncology (ESGO) together with the European Society of Human Reproduction and Embryology (ESHRE) and the European Society for Gynaecological Endoscopy (ESGE) is developing clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing treatment in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwilde (patients selection, tumour clinicopathological characteristics, treatment, special issues). The multidisciplinary international group consists of expert practising clinicians, researchers in the fields of gynecological oncology, human reproduction, endoscopy, and histopathology. The development group is chaired by Prof. Alexandros Rodolakis (ESGO, Greece), Dr. Kirsten Louise Tryde Macklon (ESHRE, Denmark) and Prof. Giovanni Scambia (ESGE, Italy). The article publication is expected in 2022. Not Yet a Certified Center? View the process! Directly to: Certified Centers Ovarian Cancer Surgery Webcasts Vulvar Cancer Management Guidelines ESGO Newsletter Get notified on all news and activities right in your mailbox. Sign-up Now! You May Also Like Advanced Ovarian Cancer Surgery Quality Indicators Read More Endometrial Cancer Guidelines Free Download Read More Cervical Cancer Management Latest Algorithms Read More Vulvar Cancer Guidelines Guidelines Read More ESGO Guidelines Guidelines development is one of the core activities of the European Society of Gynaecological Oncology. Read more Contact us: firstname.lastname@example.org About Guidelines in development Ovarian Cancer Surgery Quality Indicators Certification Certified Centers ESGO Guidelines Cervical Cancer Ovarian Cancer Endometrial Cancer Vulvar Cancer ESGO ALG App For iPhone Devices For Android Devices News Updates Get notified on all of ESGO’s news and activities. Sign-up Now!